Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation TCT 2025

TCT 306: Oxygen Desaturation During Stress Tests to Identify Migraineurs with Functionally Significant Patent Foramen Ovale

Presenter: Sammy Shaker

October 26, 2025

Presentation TCT 2023

PFO Closure for Migraine: Update on the RELIEF Clinical Study

Presenter: Robert Sommer

October 26, 2023

Presentation TCT 2022

Your Migraine, My Migraine: How Seriously Should We Be Thinking About PFO?

Presenter: Robert Sommer

September 18, 2022

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

Presentation TCT 2020

TCT 198: A Platelet-Associated Pathophysiologic Mechanism Linking Patent Foramen Ovale and Migraine

Presenter: Daniela Trabattoni

October 14, 2020

Presentation TCT 2020

TCT 195: Percutaneous Patent Foramen Ovale Closure for Migraine with the Amplatzer PFO Occluder: A Pooled Analysis of Individual Participant Data from the Randomized Trials

Presenter: Preetham Kumar

October 14, 2020

Presentation TCT 2019

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Presenter: Mark Reisman

September 27, 2019

Presentation TCT 2018

A Patient With Migraine With Aura Mimicking TIA: Is PFO Closure Appropriate?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Presentation TCT 2018

Case #4: Should This PFO be Closed in a Patient With a Migraine?

Presenter: Robert J. Sommer, Christian Spies, Suzanne J. Baron, Reda Ibrahim, Carey D. Kimmelstiel, Srihari S. Naidu, Zoltan G. Turi, Dominik M. Wiktor

September 22, 2018

Presentation TCT 2018

PFO Closure for Migraine: Current Status

Presenter: Michael J. Mullen, David E. Thaler, Robert J. Sommer

September 22, 2018

Presentation TCT 2017

PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial?

Presenter: Mark Reisman, Brian K. Whisenant, Robert J. Sommer

November 01, 2017

Presentation TCT 2016

Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke

Presenter: John D. Carroll, David E. Thaler, Mark Reisman

November 01, 2016

Presentation TCT 2015

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

Presenter: David Hildick-Smith, Jonathan M. Tobis, Robert J. Sommer

October 14, 2015

Presentation TCT 2015

TCT 30: PREMIUM Trial Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

Presenter: John P. Cheatham, Carlos Pedra, Jonathan M. Tobis

October 13, 2015

News Conference News TCT 2015

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

October 11, 2015

$PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura$

Presentation TCT 2014

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, David Hildick-Smith

September 16, 2014

News Conference News TCT 2014

PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year

Yael L. Maxwell

September 16, 2014

Presentation TCT 2014

PFO/ASD Closure with a New Bioreabsorbable Device: Important Advance?

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, Sameer Gafoor

September 13, 2014

Presentation TCT 2014

PFO and Sleep Apnea

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, Michael J. Mullen

September 13, 2014

Presentation TCT 2014

Orthodeoxia-Platypnea

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, John C. Messenger

September 13, 2014

Advertisement

TCT 306: Oxygen Desaturation During Stress Tests to Identify Migraineurs with Functionally Significant Patent Foramen Ovale

PFO Closure for Migraine: Update on the RELIEF Clinical Study

Your Migraine, My Migraine: How Seriously Should We Be Thinking About PFO?

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

TCT 198: A Platelet-Associated Pathophysiologic Mechanism Linking Patent Foramen Ovale and Migraine

TCT 195: Percutaneous Patent Foramen Ovale Closure for Migraine with the Amplatzer PFO Occluder: A Pooled Analysis of Individual Participant Data from the Randomized Trials

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

A Patient With Migraine With Aura Mimicking TIA: Is PFO Closure Appropriate?

Case #4: Should This PFO be Closed in a Patient With a Migraine?

PFO Closure for Migraine: Current Status

PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial?

Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

TCT 30: PREMIUM Trial Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year

PFO/ASD Closure with a New Bioreabsorbable Device: Important Advance?

PFO and Sleep Apnea

Orthodeoxia-Platypnea

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content